Dr. Rao Khurram Ayoub

Medically reviewed by Dr. Rao Khurram Ayoub, RPh, PhD (Pharmaceutics)

Written by Dr. Muhammad Imran, M.Phil, PharmD, BSc

Updated on

⚡ In This ADHD Guide:
ADHD Symptom Tracker | Female Prep Checklist | Estrogen & ADHD Severity | Perimenopause Symptom Tracker | Medication Timing (Chronotherapy)
Quick Answer: ADHD affects 5.9% of children and 2.5% of adults globally (Faraone et al., 2021). Approximately 15% retain full syndrome by age 25, while 65% retain residual symptoms (Faraone et al., 2006). ADHD is linked to frontostriatal circuit dysfunction and diagnosed using DSM-5 criteria (≥5 symptoms in adults, ≥6 in children, ≥6 months, in ≥2 settings).

What is Attention Deficit Hyperactivity Disorder (ADHD)?

ADHD is a complex, lifelong neurodevelopmental condition that affects attention, impulse control, and activity levels. It has three recognised presentations:

  • Inattentive: forgetfulness, disorganisation, difficulty sustaining focus
  • Hyperactive-impulsive: restlessness, excessive talking, impulsive decisions
  • Combined: features of both
ADHD Spectrum - Inattentive, Hyperactive-Impulsive, Combined presentations

The Neurobiology and Causes of ADHD

ADHD is linked to executive dysfunction in the frontostriatal circuits regulating attention, planning, and inhibition. Neuroimaging shows reduced prefrontal cortex activity and altered white matter integrity of frontostriatal tracts (Shang et al., 2013). Dopamine and noradrenaline imbalances play a central role.

Neurobiology of ADHD - Frontostriatal circuit dysfunction

Symptoms and Clinical Presentation Across the Lifespan

ADHD Symptoms in Children and Adolescents

ADHD symptoms in children and adolescents
  • Fidgeting and restlessness
  • Difficulty following instructions and careless mistakes
  • Impulsive behaviour

How Adult ADHD Manifests Differently

ADHD symptoms in adults - Time management, emotional dysregulation
  • Poor time management, forgetfulness and disorganisation
  • Emotional dysregulation and difficulty sustaining attention at work
  • Hyperactive traits in childhood may shift to inattentive features in adulthood
DSM-5 Diagnostic Reference

DSM-5 Criteria for ADHD - Interactive Checklist

Based on APA DSM-5-TR (2013/2022). Select symptoms present for ≥6 months. ≥6 for children ≤16y, ≥5 for adults 17+ in either domain.

A. Inattention Symptoms

B. Hyperactivity-Impulsivity Symptoms

Select symptoms to evaluate
Inattention: 0/9 | Hyperactivity: 0/9 | DSM-5 threshold not met

Disclaimer: For educational screening only, not diagnosis. Only qualified professional can diagnose ADHD.

Clinical Diagnostic Protocol

ADHD Clinical Assessment (NICE NG87 Framework)

Structured evaluation protocol integrating developmental history, collateral data, and differential exclusions.

1. Structured Clinical Assessment Criteria

2. Collateral History & Informant Data

3. Differential Exclusion Matrix

4. Diagnostic Alignment Summary

NICE NG87 Evaluation Status
Criteria Incomplete

Complete all diagnostic pillars and exclusions.

Evidence-Based Treatment and Clinical Management

Pharmacological Interventions

Stimulants (methylphenidate, amphetamines) are first-line. Non-stimulants (atomoxetine, guanfacine) are alternatives (Cortese et al., 2018).

Non-Pharmacological Strategies

CBT improves organisation and emotional regulation. Lifestyle: sleep hygiene, structured routines, reduced caffeine, mindfulness (NICE NG87, 2018).

Frequently Asked Questions

Is ADHD only a childhood disorder?

No. 15% retain full syndrome by age 25, 65% retain residual symptoms (Faraone et al., 2006).

Can ADHD be treated without medication?

Yes. CBT and lifestyle are less effective alone but useful combined (Faraone et al., 2021).

Is ADHD overdiagnosed?

Worldwide prevalence ~5.9% children, 2.5% adults with standard criteria (Polanczyk et al., 2007).

Validated Evidence & References (Harvard)

  • Faraone, S.V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M.A., Newcorn, J.H., Gignac, M., Al Saud, N.M., Manor, I. and Rohde, L.A., 2021. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, pp.789–818. doi:10.1016/j.neubiorev.2021.01.022
  • Faraone, S.V., Biederman, J. and Mick, E., 2006. The age-dependent decline of ADHD: a meta-analysis of follow-up studies. Psychological Medicine, 36(2), pp.159–165. doi:10.1017/S003329170500471X
  • Polanczyk, G., de Lima, M.S., Horta, B.L., Biederman, J. and Rohde, L.A., 2007. The worldwide prevalence of ADHD: systematic review and metaregression. Am J Psychiatry, 164(6), pp.942–948.
  • Shang, C.Y., Wu, Y.H., Gau, S.S. and Tseng, W.Y., 2013. Disturbed microstructural integrity of frontostriatal fiber pathways in ADHD. Human Brain Mapping, 34(5), pp.1092–1107.
  • Cortese, S. et al., 2018. Comparative efficacy of ADHD medications: systematic review and network meta-analysis. Lancet Psychiatry, 5(9), pp.727–738.
  • Thapar, A. and Cooper, M., 2016. Attention deficit hyperactivity disorder. The Lancet, 387, pp.1240–1250.
  • NICE, 2018. ADHD: diagnosis and management (NG87). Available at: https://www.nice.org.uk/guidance/ng87

Author: Dr. Muhammad Imran, M.Phil Pharmaceutics, RPh | Reviewed by Dr. Mian Muhammad Sarfraz, SCFHS, Pharm.D | Updated: Oct 12, 2026

🔗 Related Conditions

Neurotransmitter dysregulation links several conditions. Explore related hubs:

ADHD Live Estimate Global

Estimated number of people worldwide living with clinically significant ADHD symptoms, based on pooled prevalence rates.
Updated --:--:-- --
Adults with symptomatic ADHD
405,130,802
6.76% global adult prevalence · Song et al. 2021
Adults with persistent childhood ADHD
154,620,927
2.58% global adult prevalence
Children & adolescents
142,860,575
5.29–7.6% pooled prevalence
References:
1. Song P, Zha M, Yang Q, et al. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health. 2021;11:04009. doi:10.7189/jogh.11.04009
2. Salari N, Ghasemi H, Abdoli N, et al. The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis. Ital J Pediatr. 2023;49(1):48. doi:10.1186/s13052-023-01456-1
Estimates derived from pooled prevalence rates applied to current global population projections (~8.2 billion, 2026). 73% adults (18+), 27% children. Individual prevalence varies by diagnostic practices.
Was this article helpful?
1 vote · Your choice helps us improve